A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

PHASE3UnknownINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

December 31, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions

HypertensionHyperlipidemias

Interventions

DRUG

(D) DWC202206

Drug of DWC202206 A mg

DRUG

(D) DWC202207

Drug of DWC202207 B/C mg

DRUG

(P) DWC202206

Placebo of DWC202206 A mg

DRUG

(P) DWC202207

Placebo of DWC202207 B/C mg